Local and Global News
Today, BioTalent Canada and BioAlberta announced a joint launch of The PetriDish™ BioAlberta job board -- giving Alberta bio-economy employers a tried and tested platform to attract highly-skilled talent.
48Hour Discovery Inc. (48HD), a biopharmaceutical company specializing in peptide-derived drug discovery announced today that the company has entered into a strategic research collaboration with Fusion Pharmaceuticals.
VaxAlta Inc., an animal health biotechnology company focused on the development of new vaccines who has entered into a licensing & collaboration agreement w/ Scandinavian Biopharma Holdings
Accreditation issued by the Canadian Association for Laboratory Accreditation (CALA) for the testing of cannabis and natural health products at its laboratories in Leduc, Alberta.
Targets high quality mRNA COVID-19 vaccine to low-to middle-income countries at affordable prices.
QuantumCyte implements Scispot's platform to automate workflows and increase scientific output
Building a Patient-Centered Community by Generating Meaningful Data, Enhancing Collaborations, and Accelerating Outcomes
With more than $1 billion in revenues generated by Alberta companies and over 12,000 jobs expected to stem from the industry, the province's life sciences ecosystem has demonstrated strong performance and continued positive momentum..
BioAlberta announced the recipients of its 2020 Achievement Awards in recognition of the outstanding contributions of the individuals and companies whose innovation and achievements have contributed to the growing success of Alberta's life sciences sector
Culture Biosciences, a San Francisco-based technology company enabling biotech firms to develop manufacturing processes in the cloud, selected Scispot as its exclusive platform to automate workflows.
This licence allows PBG to diversify its GMP-compliant manufacturing business through the addition of natural health products including nutraceuticals, herbal remedies, vitamins, minerals and other non-prescription over the counter therapeutics.
BioAlberta remains opposed to both the process and content of Health Canada's PMPRB draft regulation proposals since they were first published.
CanBiocin companion animal probiotic currently undergoing European Food Safety Authority (EFSA) review
The Standard Processing Licence allows PBG to process and/or sell cannabis/hemp derived ingredients including extracts, concentrate, and isolates to other licenced partners.
Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction.
48Hour Discovery Inc and RayzeBio announce research collaboration to discover and develop novel peptide-based radiopharmaceuticals to treat cancer.
FREDsense Technologies Corp. announces the closing of a Convertible Debenture valued at $2.5 million from BDC Capital's Cleantech Practice.
As part of this partnership, HelaPlex will gain access to a white label digital operating platform powered by Scispot.
The company strives to empower entrepreneurs to start and virtually run their biotech startups from garages, coffee shops, dorm rooms, or anywhere else innovation is born.
MACH32 and Andau Medical announced today that the Aerosol Containment Tent (ACT) has been successfully adopted by University Health Network in Toronto, Ontario
Firm also announces strategic partnership with Ayming Canada to help businesses maximize funding